EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer

Le Vu Duy, Pham Thi Huong, Nguyen Trung Nam, Do Thi Trang, Nghiem Thi Minh Chau, Tran Thi Phuong Thao, Nguyen Huy Hoang, Nguyen Thien Tao, Can Van Mao, Nguyen Thi Xuan

Frontiers in Bioscience-Landmark · 2024

DOI: 10.31083/j.fbl2907256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Le Vu Duy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Center, 103 Military Hospital, Vietnam Military Medical University, Ha Dong, 151530 Hanoi, Vietnam. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Prostatic Neoplasms, Toll-Like Receptor 4, Deubiquitinating Enzyme CYLD. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vietnam Academy of Science and Technology (VAST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) is one of the most common malignant tumors of the male urinary system, and its incidence and mortality rates have been increasing worldwide. Benign prostatic hyperplasia (BPH) represents stromal and epithelial cell proliferation in the prostate in elderly males. Abnormal activation of inflammation-related signalling molecules, such as toll-like receptor 4 (TLR4) and Janus kinase/signal transducers and activators of transcription (JAK/STAT) has been linked to the initiation and progression of various human diseases including PCa and BPH. Cylindromatosis (CYLD) gene alterations are associated with PCa progression. In this study, the contribution of CYLD, JAK2, and TLR4 gene variants to PCa and BPH risks and their associations with prostate-specific antigen (PSA) levels, immunophenotype, and clinical features in Vietnamese men were determined.

Methods

A total of 102 patients with PCa, 65 with BPH, and 114 healthy controls were enrolled. The immunophenotype was analyzed by flow cytometry, cytokine secretion by enzyme-linked immunosorbent assay (ELISA), and gene variants by DNA sequencing.

Results

Lower levels of transforming growth factor β (TGF-β) and higher numbers of CD13+CD117- and CD56+CD25+ cells were observed in the PCa group than in the BPH group. Genetic analysis of the CYLD gene identified five single nucleotide polymorphisms (SNPs), of which c.2351-47 C>T, c.2351-46A>T, and rs1971432171 T>G had significantly higher frequencies in PCa patients than in the control and BPH groups. Sequencing of the TLR4 gene revealed five nucleotide changes, in which the rs2149356 SNP showed an increased risk for both PCa and BPH and the c.331-206 SNP had a reduced risk for PCa. Importantly, the expansion of activated natural killer (NK) cells and higher levels of PSA were found in PCa patients carrying the CT genotype of the CYLD c.2351-47 compared to those with the wild-type genotype.

Conclusion

Activation of NK cells in CYLD-sensitive PCa patients was associated with serum PSA release and the CYLD c.2351-47 variant may be a significant risk factor for prostatitis in PCa patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaProstatic NeoplasmsToll-Like Receptor 4Deubiquitinating Enzyme CYLDProstate-Specific AntigenJanus Kinase 2HumansMaleAgedMiddle AgedImmunophenotypingGenotypePolymorphism, Single NucleotideCase-Control Studies

Stichwörter der Autor:innen

CYLDJAK2TLR4benign prostatic hyperplasiaprostate cancer

Substanzen

Toll-Like Receptor 4Deubiquitinating Enzyme CYLDProstate-Specific AntigenTLR4 protein, humanJanus Kinase 2CYLD protein, humanJAK2 protein, human

Autor:innen und Institutionen

  • Oncology Center, 103 Military Hospital, Vietnam Military Medical University, Ha Dong, 151530 Hanoi, Vietnam.
  • Radiology Center, 103 Military Hospital, Vietnam Military Medical University, Ha Dong, 151530 Hanoi, Vietnam.
  • Institute of Genome Research, Vietnam Academy of Science and Technology, Cau Giay, 122300 Hanoi, Vietnam.
  • Institute of Biotechnology, Vietnam Academy of Science and Technology, Cau Giay, 122300 Hanoi, Vietnam.
  • Department of Pathophysiology, Vietnam Military Medical University, Ha Dong, 151530 Hanoi, Vietnam.

Förderung

  • Vietnam Academy of Science and Technology (VAST)

Zitieren

APA

Duy, L. V., Huong, P. T., Nam, N. T., Trang, D. T., Chau, N. T. M., Thao, T. T. P., Hoang, N. H., Tao, N. T., Mao, C. V., & Xuan, N. T. (2024). Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907256

Vancouver

Duy LV, Huong PT, Nam NT, Trang DT, Chau NTM, Thao TTP, et al. Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907256

BibTeX
@article{Duy2024,
  author = {Duy, Le Vu and Huong, Pham Thi and Nam, Nguyen Trung and Trang, Do Thi and Chau, Nghiem Thi Minh and Thao, Tran Thi Phuong and Hoang, Nguyen Huy and Tao, Nguyen Thien and Mao, Can Van and Xuan, Nguyen Thi},
  title = {Associations of CYLD, JAK2 and TLR4 Genotypes with PSA Levels and Immunophenotype in Benign Prostatic Hyperplasia and Prostate Cancer},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  doi = {10.31083/j.fbl2907256}
}
Kostenlos starten →